NYSE · PEAK
Real Estate · REIT - Healthcare Facilities
$17.10
Up+$0.35 (+2.09%)
Updated Sep 16, 2026, 9:18 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
PEAK does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning PEAK.
PEAK research
Company profile and research snapshot.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 4, 2024 | Scotiabank | Sector Outperform | — |
| Jan 30, 2024 | Deutsche Bank | Hold | — |
| Jan 12, 2024 | Scotiabank | Sector Outperform | — |
| Oct 31, 2023 | Wedbush | Neutral | — |
| Oct 11, 2023 | Exane BNP Paribas | Underperform | — |
No generated briefing is available yet.
globenewswire.com · Nov 10, 2025
16.5 months median progression free survival (mPFS) for bezuclastinib plus sunitinib compared to 9.2 months mPFS for sunitinib monotherapy (HR=0.50, CI: 0.39-0.65; p
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PEAK.
No results
No recent SID articles mention PEAK.
